Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page
Unlocking the Emerging Opportunities in India’s Pharmaceutical Industry

Unlocking the Emerging Opportunities in India’s Pharmaceutical Industry

by Team Small News | May 22, 2025 | Aurobindo Pharma, Natco, Pharma, Piramal Pharma, Zydus

The Indian pharmaceutical sector has demonstrated robust growth over the past year, driven by a new trade agreement with the European Union that reduces tariffs on key drug exports. This agreement is expected to enhance India’s position as a global supplier of...
Uncertainty in US Policy Hinders Pharmaceutical Investment Decisions

Uncertainty in US Policy Hinders Pharmaceutical Investment Decisions

by Team Small News | May 17, 2025 | Pharma, Piramal Pharma

The pharmaceutical industry is experiencing a period of uncertainty due to recent US policy directives, which are causing global pharmaceutical companies to delay major outsourcing decisions. Piramal Pharma, a contract development and manufacturing organization...
Uncertainty in US Policy Hinders Pharmaceutical Investment Decisions

Piramal Pharma receives regulatory approval to market Neoatricon in the UK, paving the way for its availability in the market.

by Team Small News | Mar 21, 2025 | Pharma, Piramal Pharma

Piramal Pharma Limited, in collaboration with BrePco Biopharma Ltd, has received regulatory approval from the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) for Naeoatricon, a new pediatric-strength dopamine hydrochloride infusion for the...
Uncertainty in US Policy Hinders Pharmaceutical Investment Decisions

Piramal Pharma sets its sights on ambitious $2 billion revenue target by FY30, poised for a decade of exponential growth.

by Team Small News | Mar 19, 2025 | Pharma, Piramal Pharma

Piramal Pharma, a multi-faceted pharmaceutical company, is poised to achieve its goal of reaching $2 billion in revenues and becoming one of the top 10 companies in its addressable markets by 2030, according to Chairperson Nandini Piramal. The company has been growing...
Next Entries »

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress